| The Cooper Companies is a global medical device company. Co.'s business units are CooperVision and CooperSurgical. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses. CooperVision also manufactures and markets myopia management and specialty eyecare products. CooperSurgical's business engages in the general health care market with a focus on improving the health of women, babies and families. Co.'s fertility portfolio includes medical device coverage of the in vitro fertilization cycle, egg and sperm donation, and cryopreservation. Co.'s office and surgical platform includes various medical devices used in gynecology and obstetrics. We show 56 historical shares outstanding datapoints in our coverage of COO's shares outstanding history.
Understanding the changing numbers of COO shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like COO versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching COO by allowing them to research COO shares outstanding history
as well as any other stock in our coverage universe.